Identifiers
HUGO:ICAM2
Maps_Modules
MODULE:INPUT_ACTIVATORS MODULE:TUMOR_RECOGNTITON MODULE:INTEGRINS
References
NATURAL_KILLER
CASCADE:LFA1
PMID:20955708
ICAM2 is Associated With a Potential Anti-Tumor Immune Response in Early Intraepithelial Stages of Human Pancreatic Carcinogenesis.
The anti-tumor immune reaction changed from an immune response to immune tolerance between the stages of intraductal papillary mucinous adenoma (IPMA) and intraductal papillary mucinous carcinoma (IPMC).
Expression levels oF ICAM2 is up-regulated exclusively in IPMA and disappeared from IPMC.